Dr. Rebecca Rawl, MD

NPI: 1467778555
Total Payments
$594.06
2024 Payments
$204.90
Companies
8
Transactions
16
Medicare Patients
1,439
Medicare Billing
$142,173

Payment Breakdown by Category

Food & Beverage$594.06 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $594.06 16 100.0%

Top Paying Companies

Company Total Records Latest Year
Enterra Medical, Inc. $145.37 1 $0 (2024)
PFIZER INC. $130.16 4 $0 (2018)
ABBVIE INC. $129.97 3 $0 (2024)
Merck Sharp & Dohme Corporation $114.36 3 $0 (2019)
Janssen Biotech, Inc. $26.36 2 $0 (2024)
Ipsen Biopharmaceuticals, Inc $16.90 1 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.50 1 $0 (2018)
QOL Medical, LLC $15.44 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $204.90 4 Enterra Medical, Inc. ($145.37)
2019 $27.79 2 QOL Medical, LLC ($15.44)
2018 $269.42 9 PFIZER INC. ($130.16)
2017 $91.95 1 AbbVie, Inc. ($91.95)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $27.08 General
Category: IMMUNOLOGY
10/08/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $15.55 General
Category: Immunology
04/15/2024 Enterra Medical, Inc. Food and Beverage In-kind items and services $145.37 General
03/14/2024 Ipsen Biopharmaceuticals, Inc Bylvay (Drug) Food and Beverage In-kind items and services $16.90 General
Category: Gastroenterology
07/11/2019 QOL Medical, LLC Sucraid (Drug) Food and Beverage Cash or cash equivalent $15.44 General
Category: THERAPY FOR CSID
04/11/2019 Merck Sharp & Dohme Corporation DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $12.35 General
Category: INFECTIOUS DISEASE
12/06/2018 Merck Sharp & Dohme Corporation ZINPLAVA (Biological), RENFLEXIS Food and Beverage In-kind items and services $11.57 General
Category: INFECTIOUS DISEASE
11/28/2018 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $100.64 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
08/17/2018 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $9.52 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
06/15/2018 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $10.81 General
Category: Immunology
06/11/2018 Merck Sharp & Dohme Corporation DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $90.44 General
Category: INFECTIOUS DISEASE
06/01/2018 PFIZER INC. INFLECTRA (Biological) Food and Beverage In-kind items and services $10.00 General
Category: INFLAMMATION
02/23/2018 AbbVie, Inc. Mavyret (Drug) Food and Beverage In-kind items and services $10.94 General
Category: Virology
02/09/2018 PFIZER INC. INFLECTRA (Biological) Food and Beverage In-kind items and services $10.00 General
Category: INFLAMMATION
01/02/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.50 General
Category: GASTROENTEROLOGY
02/15/2017 AbbVie, Inc. Food and Beverage In-kind items and services $91.95 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 346 369 $205,260 $35,941
2022 9 334 363 $151,410 $32,664
2021 11 338 370 $122,702 $33,277
2020 10 421 502 $166,232 $40,290
Total Patients
1,439
Total Services
1,604
Medicare Billing
$142,173
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 30 30 $37,860 $5,526 14.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 54 60 $20,220 $5,028 24.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 50 50 $23,150 $5,024 21.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 28 28 $15,260 $3,721 24.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 33 33 $29,792 $3,597 12.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 39 55 $12,650 $3,333 26.3%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 19 19 $16,834 $3,167 18.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 42 43 $29,486 $3,063 10.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 14 14 $6,104 $1,313 21.5%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 11 11 $6,545 $967.37 14.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 13 $2,990 $822.96 27.5%
43450 Dilation of esophagus Facility 2023 13 13 $4,369 $379.19 8.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 72 76 $19,291 $6,300 32.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 61 61 $24,551 $6,079 24.8%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 35 35 $15,946 $5,339 33.5%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 25 26 $32,812 $4,380 13.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 53 74 $13,324 $4,051 30.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 35 35 $23,170 $2,705 11.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 26 28 $5,283 $1,664 31.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 15 16 $13,832 $1,151 8.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 12 12 $3,201 $994.85 31.1%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 58 58 $18,618 $6,898 37.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 67 68 $14,144 $6,260 44.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 51 80 $11,360 $4,143 36.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 23 24 $9,504 $3,706 39.0%

About Dr. Rebecca Rawl, MD

Dr. Rebecca Rawl, MD is a Gastroenterology healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2010. The National Provider Identifier (NPI) number assigned to this provider is 1467778555.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Rawl, MD has received a total of $594.06 in payments from pharmaceutical and medical device companies, with $204.90 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($594.06).

As a Medicare-enrolled provider, Rawl has provided services to 1,439 Medicare beneficiaries, totaling 1,604 services with total Medicare billing of $142,173. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Internal Medicine
  • Location Huntersville, NC
  • Active Since 04/14/2010
  • Last Updated 06/17/2025
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1467778555

Products in Payments

  • XELJANZ (Drug) $110.16
  • DIFICID (Drug) $102.79
  • RINVOQ (Biological) $27.08
  • INFLECTRA (Biological) $20.00
  • Bylvay (Drug) $16.90
  • TREMFYA (Drug) $15.55
  • XIFAXAN (Drug) $15.50
  • Sucraid (Drug) $15.44
  • ZINPLAVA (Biological) $11.57
  • Mavyret (Drug) $10.94
  • STELARA (Biological) $10.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Huntersville